nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—ABCB1—kidney cancer	0.121	1	CbGaD
Pimozide—CYP3A7—Temsirolimus—kidney cancer	0.0477	0.0798	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0477	0.0798	CbGbCtD
Pimozide—CYP3A5—Temsirolimus—kidney cancer	0.0358	0.0599	CbGbCtD
Pimozide—ABCB1—Temsirolimus—kidney cancer	0.0233	0.039	CbGbCtD
Pimozide—KCNH2—Sunitinib—kidney cancer	0.023	0.0385	CbGbCtD
Pimozide—CYP2D6—Temsirolimus—kidney cancer	0.022	0.0367	CbGbCtD
Pimozide—CYP3A4—Everolimus—kidney cancer	0.0207	0.0346	CbGbCtD
Pimozide—CYP3A7—Paclitaxel—kidney cancer	0.0164	0.0274	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0164	0.0274	CbGbCtD
Pimozide—CYP3A7—Sorafenib—kidney cancer	0.0145	0.0243	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0145	0.0243	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0141	0.0236	CbGbCtD
Pimozide—CYP3A7—Vincristine—kidney cancer	0.0141	0.0236	CbGbCtD
Pimozide—CYP1A2—Pazopanib—kidney cancer	0.014	0.0234	CbGbCtD
Pimozide—CYP3A4—Temsirolimus—kidney cancer	0.014	0.0233	CbGbCtD
Pimozide—CYP3A5—Erlotinib—kidney cancer	0.0134	0.0224	CbGbCtD
Pimozide—CYP3A5—Paclitaxel—kidney cancer	0.0123	0.0205	CbGbCtD
Pimozide—ABCB1—Pazopanib—kidney cancer	0.0122	0.0205	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0118	0.0197	CbGbCtD
Pimozide—CYP3A7—Sunitinib—kidney cancer	0.0118	0.0197	CbGbCtD
Pimozide—CYP2D6—Pazopanib—kidney cancer	0.0115	0.0193	CbGbCtD
Pimozide—ABCB1—Dactinomycin—kidney cancer	0.0112	0.0187	CbGbCtD
Pimozide—CYP3A5—Sorafenib—kidney cancer	0.0109	0.0182	CbGbCtD
Pimozide—CYP3A5—Vincristine—kidney cancer	0.0106	0.0177	CbGbCtD
Pimozide—CYP1A2—Erlotinib—kidney cancer	0.00999	0.0167	CbGbCtD
Pimozide—ABCB1—Gemcitabine—kidney cancer	0.00885	0.0148	CbGbCtD
Pimozide—CYP3A5—Sunitinib—kidney cancer	0.00884	0.0148	CbGbCtD
Pimozide—CYP2C19—Sorafenib—kidney cancer	0.0088	0.0147	CbGbCtD
Pimozide—ABCB1—Erlotinib—kidney cancer	0.00873	0.0146	CbGbCtD
Pimozide—CYP2D6—Erlotinib—kidney cancer	0.00823	0.0138	CbGbCtD
Pimozide—CYP1A2—Sorafenib—kidney cancer	0.00812	0.0136	CbGbCtD
Pimozide—ABCB1—Paclitaxel—kidney cancer	0.008	0.0134	CbGbCtD
Pimozide—CYP3A4—Pazopanib—kidney cancer	0.00733	0.0123	CbGbCtD
Pimozide—ABCB1—Sorafenib—kidney cancer	0.0071	0.0119	CbGbCtD
Pimozide—ABCB1—Vinblastine—kidney cancer	0.00701	0.0117	CbGbCtD
Pimozide—ABCB1—Vincristine—kidney cancer	0.00689	0.0115	CbGbCtD
Pimozide—CYP2D6—Sorafenib—kidney cancer	0.00669	0.0112	CbGbCtD
Pimozide—CYP2D6—Vinblastine—kidney cancer	0.00661	0.011	CbGbCtD
Pimozide—ABCB1—Sunitinib—kidney cancer	0.00575	0.00962	CbGbCtD
Pimozide—CYP3A4—Erlotinib—kidney cancer	0.00523	0.00875	CbGbCtD
Pimozide—CYP3A4—Paclitaxel—kidney cancer	0.00479	0.00801	CbGbCtD
Pimozide—ABCB1—Doxorubicin—kidney cancer	0.00431	0.0072	CbGbCtD
Pimozide—CYP3A4—Sorafenib—kidney cancer	0.00425	0.00711	CbGbCtD
Pimozide—CYP3A4—Vinblastine—kidney cancer	0.0042	0.00702	CbGbCtD
Pimozide—CYP3A4—Vincristine—kidney cancer	0.00413	0.00691	CbGbCtD
Pimozide—CYP2D6—Doxorubicin—kidney cancer	0.00406	0.00679	CbGbCtD
Pimozide—CYP3A4—Sunitinib—kidney cancer	0.00345	0.00576	CbGbCtD
Pimozide—CYP3A4—Doxorubicin—kidney cancer	0.00258	0.00432	CbGbCtD
Pimozide—CYP2C19—urine—kidney cancer	0.00233	0.0759	CbGeAlD
Pimozide—CYP1A2—urine—kidney cancer	0.0019	0.062	CbGeAlD
Pimozide—CYP2E1—urine—kidney cancer	0.00171	0.0558	CbGeAlD
Pimozide—HTR2A—urine—kidney cancer	0.00149	0.0485	CbGeAlD
Pimozide—CYP3A4—urine—kidney cancer	0.00138	0.0449	CbGeAlD
Pimozide—CYP2D6—urine—kidney cancer	0.00135	0.0442	CbGeAlD
Pimozide—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.00119	0.0389	CbGeAlD
Pimozide—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.00102	0.0333	CbGeAlD
Pimozide—CALM3—nephron tubule—kidney cancer	0.00084	0.0274	CbGeAlD
Pimozide—CALM3—cortex of kidney—kidney cancer	0.000719	0.0235	CbGeAlD
Pimozide—CALM3—cardiac atrium—kidney cancer	0.000684	0.0223	CbGeAlD
Pimozide—CALM2—nephron tubule—kidney cancer	0.00066	0.0215	CbGeAlD
Pimozide—CALM1—nephron tubule—kidney cancer	0.000657	0.0214	CbGeAlD
Pimozide—HTR1A—renal system—kidney cancer	0.00061	0.0199	CbGeAlD
Pimozide—CALM2—renal system—kidney cancer	0.0006	0.0196	CbGeAlD
Pimozide—CALM1—renal system—kidney cancer	0.000597	0.0195	CbGeAlD
Pimozide—CALM2—kidney—kidney cancer	0.00058	0.0189	CbGeAlD
Pimozide—CALM1—kidney—kidney cancer	0.000577	0.0188	CbGeAlD
Pimozide—CALM2—cortex of kidney—kidney cancer	0.000565	0.0184	CbGeAlD
Pimozide—CALM1—cortex of kidney—kidney cancer	0.000562	0.0183	CbGeAlD
Pimozide—KCNH2—renal system—kidney cancer	0.000543	0.0177	CbGeAlD
Pimozide—CALM2—gonad—kidney cancer	0.000538	0.0175	CbGeAlD
Pimozide—CALM2—cardiac atrium—kidney cancer	0.000537	0.0175	CbGeAlD
Pimozide—CALM1—gonad—kidney cancer	0.000535	0.0175	CbGeAlD
Pimozide—CALM1—cardiac atrium—kidney cancer	0.000535	0.0174	CbGeAlD
Pimozide—CYP3A5—nephron tubule—kidney cancer	0.000493	0.0161	CbGeAlD
Pimozide—KCNH2—cardiac atrium—kidney cancer	0.000487	0.0159	CbGeAlD
Pimozide—CYP1A2—renal system—kidney cancer	0.000465	0.0152	CbGeAlD
Pimozide—CYP2E1—nephron tubule—kidney cancer	0.00046	0.015	CbGeAlD
Pimozide—CYP3A5—renal system—kidney cancer	0.000449	0.0146	CbGeAlD
Pimozide—CYP3A5—kidney—kidney cancer	0.000434	0.0141	CbGeAlD
Pimozide—CYP3A5—cortex of kidney—kidney cancer	0.000422	0.0138	CbGeAlD
Pimozide—CYP2E1—renal system—kidney cancer	0.000418	0.0136	CbGeAlD
Pimozide—CYP2E1—kidney—kidney cancer	0.000404	0.0132	CbGeAlD
Pimozide—CYP2E1—cortex of kidney—kidney cancer	0.000394	0.0128	CbGeAlD
Pimozide—HTR2A—renal system—kidney cancer	0.000364	0.0119	CbGeAlD
Pimozide—HTR2A—kidney—kidney cancer	0.000352	0.0115	CbGeAlD
Pimozide—CYP3A4—renal system—kidney cancer	0.000337	0.011	CbGeAlD
Pimozide—CYP2D6—renal system—kidney cancer	0.000331	0.0108	CbGeAlD
Pimozide—HTR2A—gonad—kidney cancer	0.000326	0.0106	CbGeAlD
Pimozide—CYP3A4—kidney—kidney cancer	0.000325	0.0106	CbGeAlD
Pimozide—CYP2D6—kidney—kidney cancer	0.00032	0.0104	CbGeAlD
Pimozide—Flunarizine—CYP1A1—kidney cancer	0.000303	0.248	CrCbGaD
Pimozide—Ezetimibe—ABCB1—kidney cancer	0.000274	0.224	CrCbGaD
Pimozide—Astemizole—ABCB1—kidney cancer	0.000274	0.224	CrCbGaD
Pimozide—ABCB1—nephron tubule—kidney cancer	0.000262	0.00855	CbGeAlD
Pimozide—ABCB1—renal system—kidney cancer	0.000238	0.00777	CbGeAlD
Pimozide—ABCB1—kidney—kidney cancer	0.00023	0.00751	CbGeAlD
Pimozide—ABCB1—cortex of kidney—kidney cancer	0.000224	0.00732	CbGeAlD
Pimozide—ABCB1—gonad—kidney cancer	0.000214	0.00697	CbGeAlD
Pimozide—Abdominal discomfort—Capecitabine—kidney cancer	0.000213	0.00157	CcSEcCtD
Pimozide—Connective tissue disorder—Paclitaxel—kidney cancer	0.000213	0.00157	CcSEcCtD
Pimozide—Leukopenia—Vincristine—kidney cancer	0.000212	0.00157	CcSEcCtD
Pimozide—Pancytopenia—Capecitabine—kidney cancer	0.000211	0.00156	CcSEcCtD
Pimozide—Visual impairment—Paclitaxel—kidney cancer	0.000208	0.00154	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000208	0.00154	CcSEcCtD
Pimozide—Anaemia—Gemcitabine—kidney cancer	0.000208	0.00153	CcSEcCtD
Pimozide—Insomnia—Sunitinib—kidney cancer	0.000207	0.00153	CcSEcCtD
Pimozide—Decreased appetite—Sorafenib—kidney cancer	0.000207	0.00153	CcSEcCtD
Pimozide—Anorexia—Dactinomycin—kidney cancer	0.000206	0.00152	CcSEcCtD
Pimozide—Nausea—Pazopanib—kidney cancer	0.000206	0.00152	CcSEcCtD
Pimozide—Convulsion—Vincristine—kidney cancer	0.000205	0.00152	CcSEcCtD
Pimozide—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000205	0.00152	CcSEcCtD
Pimozide—Hypertension—Vincristine—kidney cancer	0.000205	0.00151	CcSEcCtD
Pimozide—Constipation—Sorafenib—kidney cancer	0.000203	0.0015	CcSEcCtD
Pimozide—Eye disorder—Paclitaxel—kidney cancer	0.000202	0.00149	CcSEcCtD
Pimozide—Myalgia—Vincristine—kidney cancer	0.000202	0.00149	CcSEcCtD
Pimozide—Weight increased—Capecitabine—kidney cancer	0.000202	0.00149	CcSEcCtD
Pimozide—Leukopenia—Gemcitabine—kidney cancer	0.000201	0.00149	CcSEcCtD
Pimozide—Cardiac disorder—Paclitaxel—kidney cancer	0.000201	0.00148	CcSEcCtD
Pimozide—Weight decreased—Capecitabine—kidney cancer	0.000201	0.00148	CcSEcCtD
Pimozide—Decreased appetite—Sunitinib—kidney cancer	0.000199	0.00147	CcSEcCtD
Pimozide—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000198	0.00146	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000197	0.00146	CcSEcCtD
Pimozide—Asthenia—Vinblastine—kidney cancer	0.000197	0.00146	CcSEcCtD
Pimozide—Depression—Capecitabine—kidney cancer	0.000197	0.00146	CcSEcCtD
Pimozide—Asthenia—Everolimus—kidney cancer	0.000197	0.00145	CcSEcCtD
Pimozide—Constipation—Sunitinib—kidney cancer	0.000196	0.00144	CcSEcCtD
Pimozide—Fexofenadine—ABCB1—kidney cancer	0.000195	0.159	CrCbGaD
Pimozide—Hypertension—Gemcitabine—kidney cancer	0.000194	0.00143	CcSEcCtD
Pimozide—Pruritus—Everolimus—kidney cancer	0.000194	0.00143	CcSEcCtD
Pimozide—Myalgia—Gemcitabine—kidney cancer	0.000191	0.00141	CcSEcCtD
Pimozide—Chest pain—Gemcitabine—kidney cancer	0.000191	0.00141	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.00019	0.0014	CcSEcCtD
Pimozide—Nervous system disorder—Vincristine—kidney cancer	0.00019	0.0014	CcSEcCtD
Pimozide—Asthenia—Erlotinib—kidney cancer	0.00019	0.0014	CcSEcCtD
Pimozide—Mental disorder—Paclitaxel—kidney cancer	0.00019	0.0014	CcSEcCtD
Pimozide—Urticaria—Sorafenib—kidney cancer	0.000189	0.00139	CcSEcCtD
Pimozide—Decreased appetite—Dactinomycin—kidney cancer	0.000188	0.00139	CcSEcCtD
Pimozide—Diarrhoea—Vinblastine—kidney cancer	0.000188	0.00139	CcSEcCtD
Pimozide—Diarrhoea—Everolimus—kidney cancer	0.000187	0.00138	CcSEcCtD
Pimozide—Hyperhidrosis—Vincristine—kidney cancer	0.000187	0.00138	CcSEcCtD
Pimozide—Pruritus—Erlotinib—kidney cancer	0.000187	0.00138	CcSEcCtD
Pimozide—Agranulocytosis—Capecitabine—kidney cancer	0.000185	0.00136	CcSEcCtD
Pimozide—Anorexia—Vincristine—kidney cancer	0.000184	0.00136	CcSEcCtD
Pimozide—Dizziness—Vinblastine—kidney cancer	0.000182	0.00134	CcSEcCtD
Pimozide—Dizziness—Everolimus—kidney cancer	0.000181	0.00134	CcSEcCtD
Pimozide—Muscle spasms—Paclitaxel—kidney cancer	0.000181	0.00134	CcSEcCtD
Pimozide—Diarrhoea—Erlotinib—kidney cancer	0.000181	0.00134	CcSEcCtD
Pimozide—Hypotension—Vincristine—kidney cancer	0.000181	0.00134	CcSEcCtD
Pimozide—Nervous system disorder—Gemcitabine—kidney cancer	0.00018	0.00133	CcSEcCtD
Pimozide—Skin disorder—Gemcitabine—kidney cancer	0.000178	0.00132	CcSEcCtD
Pimozide—Domperidone—ABCB1—kidney cancer	0.000178	0.145	CrCbGaD
Pimozide—Vision blurred—Paclitaxel—kidney cancer	0.000177	0.00131	CcSEcCtD
Pimozide—Hyperhidrosis—Gemcitabine—kidney cancer	0.000177	0.00131	CcSEcCtD
Pimozide—Tremor—Paclitaxel—kidney cancer	0.000176	0.0013	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000176	0.0013	CcSEcCtD
Pimozide—Increased appetite—Doxorubicin—kidney cancer	0.000176	0.0013	CcSEcCtD
Pimozide—Insomnia—Vincristine—kidney cancer	0.000175	0.00129	CcSEcCtD
Pimozide—Anorexia—Gemcitabine—kidney cancer	0.000175	0.00129	CcSEcCtD
Pimozide—Vomiting—Vinblastine—kidney cancer	0.000175	0.00129	CcSEcCtD
Pimozide—Dizziness—Erlotinib—kidney cancer	0.000175	0.00129	CcSEcCtD
Pimozide—Connective tissue disorder—Capecitabine—kidney cancer	0.000174	0.00129	CcSEcCtD
Pimozide—Vomiting—Everolimus—kidney cancer	0.000174	0.00129	CcSEcCtD
Pimozide—Anaemia—Paclitaxel—kidney cancer	0.000174	0.00129	CcSEcCtD
Pimozide—Agitation—Paclitaxel—kidney cancer	0.000173	0.00128	CcSEcCtD
Pimozide—Rash—Everolimus—kidney cancer	0.000173	0.00128	CcSEcCtD
Pimozide—Dermatitis—Everolimus—kidney cancer	0.000173	0.00127	CcSEcCtD
Pimozide—Headache—Vinblastine—kidney cancer	0.000172	0.00127	CcSEcCtD
Pimozide—Headache—Everolimus—kidney cancer	0.000172	0.00127	CcSEcCtD
Pimozide—Hypotension—Gemcitabine—kidney cancer	0.000172	0.00127	CcSEcCtD
Pimozide—Visual impairment—Capecitabine—kidney cancer	0.000171	0.00126	CcSEcCtD
Pimozide—Asthenia—Sorafenib—kidney cancer	0.000171	0.00126	CcSEcCtD
Pimozide—Syncope—Paclitaxel—kidney cancer	0.000169	0.00125	CcSEcCtD
Pimozide—Leukopenia—Paclitaxel—kidney cancer	0.000169	0.00124	CcSEcCtD
Pimozide—Decreased appetite—Vincristine—kidney cancer	0.000168	0.00124	CcSEcCtD
Pimozide—Pruritus—Sorafenib—kidney cancer	0.000168	0.00124	CcSEcCtD
Pimozide—Vomiting—Erlotinib—kidney cancer	0.000168	0.00124	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000167	0.00123	CcSEcCtD
Pimozide—Gastrointestinal disorder—Vincristine—kidney cancer	0.000167	0.00123	CcSEcCtD
Pimozide—Rash—Erlotinib—kidney cancer	0.000167	0.00123	CcSEcCtD
Pimozide—Dermatitis—Erlotinib—kidney cancer	0.000166	0.00123	CcSEcCtD
Pimozide—Palpitations—Paclitaxel—kidney cancer	0.000166	0.00123	CcSEcCtD
Pimozide—Hyponatraemia—Doxorubicin—kidney cancer	0.000166	0.00123	CcSEcCtD
Pimozide—Insomnia—Gemcitabine—kidney cancer	0.000166	0.00123	CcSEcCtD
Pimozide—Eye disorder—Capecitabine—kidney cancer	0.000166	0.00122	CcSEcCtD
Pimozide—Headache—Erlotinib—kidney cancer	0.000166	0.00122	CcSEcCtD
Pimozide—Loss of consciousness—Paclitaxel—kidney cancer	0.000166	0.00122	CcSEcCtD
Pimozide—Constipation—Vincristine—kidney cancer	0.000165	0.00122	CcSEcCtD
Pimozide—Cardiac disorder—Capecitabine—kidney cancer	0.000165	0.00122	CcSEcCtD
Pimozide—Asthenia—Sunitinib—kidney cancer	0.000164	0.00121	CcSEcCtD
Pimozide—Nausea—Vinblastine—kidney cancer	0.000163	0.00121	CcSEcCtD
Pimozide—Somnolence—Gemcitabine—kidney cancer	0.000163	0.0012	CcSEcCtD
Pimozide—Convulsion—Paclitaxel—kidney cancer	0.000163	0.0012	CcSEcCtD
Pimozide—Nausea—Everolimus—kidney cancer	0.000163	0.0012	CcSEcCtD
Pimozide—Diarrhoea—Sorafenib—kidney cancer	0.000163	0.0012	CcSEcCtD
Pimozide—Hypertension—Paclitaxel—kidney cancer	0.000163	0.0012	CcSEcCtD
Pimozide—Pruritus—Sunitinib—kidney cancer	0.000162	0.0012	CcSEcCtD
Pimozide—Myalgia—Paclitaxel—kidney cancer	0.00016	0.00118	CcSEcCtD
Pimozide—Chest pain—Paclitaxel—kidney cancer	0.00016	0.00118	CcSEcCtD
Pimozide—Decreased appetite—Gemcitabine—kidney cancer	0.00016	0.00118	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000159	0.00118	CcSEcCtD
Pimozide—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000158	0.00117	CcSEcCtD
Pimozide—Dizziness—Sorafenib—kidney cancer	0.000157	0.00116	CcSEcCtD
Pimozide—Constipation—Gemcitabine—kidney cancer	0.000157	0.00116	CcSEcCtD
Pimozide—Nausea—Erlotinib—kidney cancer	0.000157	0.00116	CcSEcCtD
Pimozide—Dry mouth—Paclitaxel—kidney cancer	0.000157	0.00116	CcSEcCtD
Pimozide—Diarrhoea—Sunitinib—kidney cancer	0.000157	0.00116	CcSEcCtD
Pimozide—Mental disorder—Capecitabine—kidney cancer	0.000156	0.00115	CcSEcCtD
Pimozide—Asthenia—Dactinomycin—kidney cancer	0.000155	0.00115	CcSEcCtD
Pimozide—Dizziness—Sunitinib—kidney cancer	0.000151	0.00112	CcSEcCtD
Pimozide—Shock—Paclitaxel—kidney cancer	0.000151	0.00112	CcSEcCtD
Pimozide—Vomiting—Sorafenib—kidney cancer	0.000151	0.00112	CcSEcCtD
Pimozide—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000151	0.00112	CcSEcCtD
Pimozide—Nervous system disorder—Paclitaxel—kidney cancer	0.000151	0.00111	CcSEcCtD
Pimozide—Tachycardia—Paclitaxel—kidney cancer	0.00015	0.00111	CcSEcCtD
Pimozide—Rash—Sorafenib—kidney cancer	0.00015	0.00111	CcSEcCtD
Pimozide—Dermatitis—Sorafenib—kidney cancer	0.00015	0.00111	CcSEcCtD
Pimozide—Breast disorder—Doxorubicin—kidney cancer	0.000149	0.0011	CcSEcCtD
Pimozide—Skin disorder—Paclitaxel—kidney cancer	0.000149	0.0011	CcSEcCtD
Pimozide—Headache—Sorafenib—kidney cancer	0.000149	0.0011	CcSEcCtD
Pimozide—Muscle spasms—Capecitabine—kidney cancer	0.000149	0.0011	CcSEcCtD
Pimozide—Hyperhidrosis—Paclitaxel—kidney cancer	0.000149	0.0011	CcSEcCtD
Pimozide—Diarrhoea—Dactinomycin—kidney cancer	0.000148	0.00109	CcSEcCtD
Pimozide—Anorexia—Paclitaxel—kidney cancer	0.000147	0.00108	CcSEcCtD
Pimozide—Vision blurred—Capecitabine—kidney cancer	0.000146	0.00108	CcSEcCtD
Pimozide—Vomiting—Sunitinib—kidney cancer	0.000145	0.00107	CcSEcCtD
Pimozide—Tremor—Capecitabine—kidney cancer	0.000145	0.00107	CcSEcCtD
Pimozide—Rash—Sunitinib—kidney cancer	0.000144	0.00107	CcSEcCtD
Pimozide—Dermatitis—Sunitinib—kidney cancer	0.000144	0.00106	CcSEcCtD
Pimozide—Hypotension—Paclitaxel—kidney cancer	0.000144	0.00106	CcSEcCtD
Pimozide—Headache—Sunitinib—kidney cancer	0.000143	0.00106	CcSEcCtD
Pimozide—Dysphagia—Doxorubicin—kidney cancer	0.000143	0.00106	CcSEcCtD
Pimozide—Anaemia—Capecitabine—kidney cancer	0.000143	0.00105	CcSEcCtD
Pimozide—Eosinophilia—Doxorubicin—kidney cancer	0.000142	0.00105	CcSEcCtD
Pimozide—Nausea—Sorafenib—kidney cancer	0.000141	0.00104	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.00014	0.00103	CcSEcCtD
Pimozide—Insomnia—Paclitaxel—kidney cancer	0.000139	0.00103	CcSEcCtD
Pimozide—Asthenia—Vincristine—kidney cancer	0.000139	0.00103	CcSEcCtD
Pimozide—Syncope—Capecitabine—kidney cancer	0.000139	0.00102	CcSEcCtD
Pimozide—Leukopenia—Capecitabine—kidney cancer	0.000138	0.00102	CcSEcCtD
Pimozide—Vomiting—Dactinomycin—kidney cancer	0.000138	0.00102	CcSEcCtD
Pimozide—Somnolence—Paclitaxel—kidney cancer	0.000137	0.00101	CcSEcCtD
Pimozide—Palpitations—Capecitabine—kidney cancer	0.000137	0.00101	CcSEcCtD
Pimozide—Rash—Dactinomycin—kidney cancer	0.000137	0.00101	CcSEcCtD
Pimozide—Nausea—Sunitinib—kidney cancer	0.000136	0.001	CcSEcCtD
Pimozide—Loss of consciousness—Capecitabine—kidney cancer	0.000136	0.001	CcSEcCtD
Pimozide—Pancytopenia—Doxorubicin—kidney cancer	0.000136	0.001	CcSEcCtD
Pimozide—Decreased appetite—Paclitaxel—kidney cancer	0.000134	0.000986	CcSEcCtD
Pimozide—Hypertension—Capecitabine—kidney cancer	0.000133	0.000985	CcSEcCtD
Pimozide—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000133	0.00098	CcSEcCtD
Pimozide—Diarrhoea—Vincristine—kidney cancer	0.000132	0.000978	CcSEcCtD
Pimozide—Pollakiuria—Doxorubicin—kidney cancer	0.000132	0.000975	CcSEcCtD
Pimozide—Asthenia—Gemcitabine—kidney cancer	0.000132	0.000972	CcSEcCtD
Pimozide—Chest pain—Capecitabine—kidney cancer	0.000132	0.000971	CcSEcCtD
Pimozide—Myalgia—Capecitabine—kidney cancer	0.000132	0.000971	CcSEcCtD
Pimozide—Constipation—Paclitaxel—kidney cancer	0.000131	0.00097	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000131	0.000965	CcSEcCtD
Pimozide—Weight increased—Doxorubicin—kidney cancer	0.00013	0.000961	CcSEcCtD
Pimozide—Pruritus—Gemcitabine—kidney cancer	0.00013	0.000959	CcSEcCtD
Pimozide—Weight decreased—Doxorubicin—kidney cancer	0.000129	0.000955	CcSEcCtD
Pimozide—Dry mouth—Capecitabine—kidney cancer	0.000129	0.00095	CcSEcCtD
Pimozide—Nausea—Dactinomycin—kidney cancer	0.000129	0.00095	CcSEcCtD
Pimozide—Dizziness—Vincristine—kidney cancer	0.000128	0.000945	CcSEcCtD
Pimozide—Drowsiness—Doxorubicin—kidney cancer	0.000127	0.000941	CcSEcCtD
Pimozide—Diarrhoea—Gemcitabine—kidney cancer	0.000126	0.000927	CcSEcCtD
Pimozide—Shock—Capecitabine—kidney cancer	0.000124	0.000916	CcSEcCtD
Pimozide—Nervous system disorder—Capecitabine—kidney cancer	0.000124	0.000913	CcSEcCtD
Pimozide—Tachycardia—Capecitabine—kidney cancer	0.000123	0.000909	CcSEcCtD
Pimozide—Vomiting—Vincristine—kidney cancer	0.000123	0.000908	CcSEcCtD
Pimozide—Skin disorder—Capecitabine—kidney cancer	0.000123	0.000905	CcSEcCtD
Pimozide—Sweating—Doxorubicin—kidney cancer	0.000122	0.000902	CcSEcCtD
Pimozide—Urticaria—Paclitaxel—kidney cancer	0.000122	0.000901	CcSEcCtD
Pimozide—Rash—Vincristine—kidney cancer	0.000122	0.000901	CcSEcCtD
Pimozide—Hyperhidrosis—Capecitabine—kidney cancer	0.000122	0.0009	CcSEcCtD
Pimozide—Dermatitis—Vincristine—kidney cancer	0.000122	0.0009	CcSEcCtD
Pimozide—Headache—Vincristine—kidney cancer	0.000121	0.000895	CcSEcCtD
Pimozide—Anorexia—Capecitabine—kidney cancer	0.00012	0.000888	CcSEcCtD
Pimozide—Agranulocytosis—Doxorubicin—kidney cancer	0.000119	0.000878	CcSEcCtD
Pimozide—Hypotension—Capecitabine—kidney cancer	0.000118	0.00087	CcSEcCtD
Pimozide—Vomiting—Gemcitabine—kidney cancer	0.000117	0.000862	CcSEcCtD
Pimozide—Rash—Gemcitabine—kidney cancer	0.000116	0.000855	CcSEcCtD
Pimozide—Dermatitis—Gemcitabine—kidney cancer	0.000116	0.000854	CcSEcCtD
Pimozide—Headache—Gemcitabine—kidney cancer	0.000115	0.000849	CcSEcCtD
Pimozide—Nausea—Vincristine—kidney cancer	0.000115	0.000849	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000115	0.000848	CcSEcCtD
Pimozide—Insomnia—Capecitabine—kidney cancer	0.000114	0.000842	CcSEcCtD
Pimozide—Connective tissue disorder—Doxorubicin—kidney cancer	0.000112	0.00083	CcSEcCtD
Pimozide—Visual impairment—Doxorubicin—kidney cancer	0.00011	0.000814	CcSEcCtD
Pimozide—Asthenia—Paclitaxel—kidney cancer	0.00011	0.000814	CcSEcCtD
Pimozide—Decreased appetite—Capecitabine—kidney cancer	0.00011	0.00081	CcSEcCtD
Pimozide—Nausea—Gemcitabine—kidney cancer	0.000109	0.000805	CcSEcCtD
Pimozide—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000109	0.000804	CcSEcCtD
Pimozide—Pruritus—Paclitaxel—kidney cancer	0.000109	0.000803	CcSEcCtD
Pimozide—Constipation—Capecitabine—kidney cancer	0.000108	0.000796	CcSEcCtD
Pimozide—Eye disorder—Doxorubicin—kidney cancer	0.000107	0.00079	CcSEcCtD
Pimozide—Cardiac disorder—Doxorubicin—kidney cancer	0.000106	0.000784	CcSEcCtD
Pimozide—Diarrhoea—Paclitaxel—kidney cancer	0.000105	0.000776	CcSEcCtD
Pimozide—Dizziness—Paclitaxel—kidney cancer	0.000102	0.00075	CcSEcCtD
Pimozide—Mental disorder—Doxorubicin—kidney cancer	0.0001	0.00074	CcSEcCtD
Pimozide—Urticaria—Capecitabine—kidney cancer	0.0001	0.00074	CcSEcCtD
Pimozide—Vomiting—Paclitaxel—kidney cancer	9.77e-05	0.000721	CcSEcCtD
Pimozide—Rash—Paclitaxel—kidney cancer	9.69e-05	0.000715	CcSEcCtD
Pimozide—Dermatitis—Paclitaxel—kidney cancer	9.68e-05	0.000715	CcSEcCtD
Pimozide—Headache—Paclitaxel—kidney cancer	9.63e-05	0.000711	CcSEcCtD
Pimozide—Muscle spasms—Doxorubicin—kidney cancer	9.58e-05	0.000707	CcSEcCtD
Pimozide—Vision blurred—Doxorubicin—kidney cancer	9.39e-05	0.000693	CcSEcCtD
Pimozide—Anaemia—Doxorubicin—kidney cancer	9.21e-05	0.00068	CcSEcCtD
Pimozide—Agitation—Doxorubicin—kidney cancer	9.15e-05	0.000676	CcSEcCtD
Pimozide—Nausea—Paclitaxel—kidney cancer	9.13e-05	0.000674	CcSEcCtD
Pimozide—Asthenia—Capecitabine—kidney cancer	9.05e-05	0.000668	CcSEcCtD
Pimozide—Syncope—Doxorubicin—kidney cancer	8.93e-05	0.00066	CcSEcCtD
Pimozide—Pruritus—Capecitabine—kidney cancer	8.92e-05	0.000659	CcSEcCtD
Pimozide—Leukopenia—Doxorubicin—kidney cancer	8.92e-05	0.000658	CcSEcCtD
Pimozide—Palpitations—Doxorubicin—kidney cancer	8.8e-05	0.00065	CcSEcCtD
Pimozide—Loss of consciousness—Doxorubicin—kidney cancer	8.76e-05	0.000646	CcSEcCtD
Pimozide—Convulsion—Doxorubicin—kidney cancer	8.63e-05	0.000637	CcSEcCtD
Pimozide—Diarrhoea—Capecitabine—kidney cancer	8.63e-05	0.000637	CcSEcCtD
Pimozide—Hypertension—Doxorubicin—kidney cancer	8.6e-05	0.000635	CcSEcCtD
Pimozide—Chest pain—Doxorubicin—kidney cancer	8.48e-05	0.000626	CcSEcCtD
Pimozide—Myalgia—Doxorubicin—kidney cancer	8.48e-05	0.000626	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	8.42e-05	0.000622	CcSEcCtD
Pimozide—Dizziness—Capecitabine—kidney cancer	8.34e-05	0.000616	CcSEcCtD
Pimozide—Dry mouth—Doxorubicin—kidney cancer	8.29e-05	0.000612	CcSEcCtD
Pimozide—Vomiting—Capecitabine—kidney cancer	8.02e-05	0.000592	CcSEcCtD
Pimozide—Shock—Doxorubicin—kidney cancer	8e-05	0.000591	CcSEcCtD
Pimozide—Nervous system disorder—Doxorubicin—kidney cancer	7.97e-05	0.000589	CcSEcCtD
Pimozide—Rash—Capecitabine—kidney cancer	7.95e-05	0.000587	CcSEcCtD
Pimozide—Dermatitis—Capecitabine—kidney cancer	7.95e-05	0.000587	CcSEcCtD
Pimozide—Tachycardia—Doxorubicin—kidney cancer	7.93e-05	0.000586	CcSEcCtD
Pimozide—Headache—Capecitabine—kidney cancer	7.9e-05	0.000583	CcSEcCtD
Pimozide—Skin disorder—Doxorubicin—kidney cancer	7.9e-05	0.000583	CcSEcCtD
Pimozide—Hyperhidrosis—Doxorubicin—kidney cancer	7.86e-05	0.00058	CcSEcCtD
Pimozide—Anorexia—Doxorubicin—kidney cancer	7.75e-05	0.000572	CcSEcCtD
Pimozide—Hypotension—Doxorubicin—kidney cancer	7.6e-05	0.000561	CcSEcCtD
Pimozide—Nausea—Capecitabine—kidney cancer	7.49e-05	0.000553	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	7.41e-05	0.000547	CcSEcCtD
Pimozide—Insomnia—Doxorubicin—kidney cancer	7.35e-05	0.000543	CcSEcCtD
Pimozide—Somnolence—Doxorubicin—kidney cancer	7.23e-05	0.000534	CcSEcCtD
Pimozide—Decreased appetite—Doxorubicin—kidney cancer	7.07e-05	0.000522	CcSEcCtD
Pimozide—Gastrointestinal disorder—Doxorubicin—kidney cancer	7.02e-05	0.000518	CcSEcCtD
Pimozide—Constipation—Doxorubicin—kidney cancer	6.95e-05	0.000513	CcSEcCtD
Pimozide—Urticaria—Doxorubicin—kidney cancer	6.46e-05	0.000477	CcSEcCtD
Pimozide—Asthenia—Doxorubicin—kidney cancer	5.83e-05	0.000431	CcSEcCtD
Pimozide—Pruritus—Doxorubicin—kidney cancer	5.75e-05	0.000425	CcSEcCtD
Pimozide—Diarrhoea—Doxorubicin—kidney cancer	5.56e-05	0.000411	CcSEcCtD
Pimozide—Dizziness—Doxorubicin—kidney cancer	5.38e-05	0.000397	CcSEcCtD
Pimozide—Vomiting—Doxorubicin—kidney cancer	5.17e-05	0.000382	CcSEcCtD
Pimozide—Rash—Doxorubicin—kidney cancer	5.13e-05	0.000378	CcSEcCtD
Pimozide—Dermatitis—Doxorubicin—kidney cancer	5.12e-05	0.000378	CcSEcCtD
Pimozide—Headache—Doxorubicin—kidney cancer	5.09e-05	0.000376	CcSEcCtD
Pimozide—Nausea—Doxorubicin—kidney cancer	4.83e-05	0.000357	CcSEcCtD
Pimozide—CALM3—Disease—CTNNB1—kidney cancer	3.37e-06	2.97e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—PIK3CA—kidney cancer	3.37e-06	2.96e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—APC—kidney cancer	3.36e-06	2.96e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—KIT—kidney cancer	3.36e-06	2.96e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—APC—kidney cancer	3.36e-06	2.96e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—KIT—kidney cancer	3.36e-06	2.96e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—VEGFA—kidney cancer	3.36e-06	2.96e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—RAF1—kidney cancer	3.34e-06	2.94e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—KRAS—kidney cancer	3.33e-06	2.93e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—MAPK3—kidney cancer	3.33e-06	2.93e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—VEGFA—kidney cancer	3.33e-06	2.93e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—RELA—kidney cancer	3.33e-06	2.93e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CCND1—kidney cancer	3.33e-06	2.93e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—JUN—kidney cancer	3.32e-06	2.92e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—PIK3CA—kidney cancer	3.31e-06	2.92e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—POMC—kidney cancer	3.31e-06	2.91e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—ERBB2—kidney cancer	3.31e-06	2.91e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—PIK3CA—kidney cancer	3.3e-06	2.91e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CTNNB1—kidney cancer	3.29e-06	2.9e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—PTEN—kidney cancer	3.29e-06	2.9e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—RAF1—kidney cancer	3.29e-06	2.9e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—RAF1—kidney cancer	3.28e-06	2.89e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—RELA—kidney cancer	3.27e-06	2.88e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—BRAF—kidney cancer	3.27e-06	2.88e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—RELA—kidney cancer	3.27e-06	2.88e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—CTNNB1—kidney cancer	3.26e-06	2.87e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—CTNNB1—kidney cancer	3.26e-06	2.87e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MTOR—kidney cancer	3.26e-06	2.87e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—ERBB2—kidney cancer	3.25e-06	2.86e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	3.25e-06	2.86e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—ERBB2—kidney cancer	3.25e-06	2.86e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—RAF1—kidney cancer	3.23e-06	2.84e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—MAPK3—kidney cancer	3.22e-06	2.84e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—MAPK3—kidney cancer	3.22e-06	2.84e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—RELA—kidney cancer	3.21e-06	2.83e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CYP1A1—kidney cancer	3.21e-06	2.83e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—PTEN—kidney cancer	3.21e-06	2.83e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MTOR—kidney cancer	3.21e-06	2.83e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MTOR—kidney cancer	3.2e-06	2.82e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—POMC—kidney cancer	3.2e-06	2.82e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—POMC—kidney cancer	3.2e-06	2.82e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—ERBB2—kidney cancer	3.19e-06	2.81e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—PTEN—kidney cancer	3.18e-06	2.8e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—PTEN—kidney cancer	3.18e-06	2.8e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—MAPK3—kidney cancer	3.18e-06	2.8e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PTGS2—kidney cancer	3.18e-06	2.8e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PTGS2—kidney cancer	3.17e-06	2.79e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—MAPK1—kidney cancer	3.17e-06	2.79e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—BRAF—kidney cancer	3.16e-06	2.78e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—BRAF—kidney cancer	3.16e-06	2.78e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PTGS2—kidney cancer	3.16e-06	2.78e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MTOR—kidney cancer	3.15e-06	2.78e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—MAPK3—kidney cancer	3.15e-06	2.77e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—PIK3CA—kidney cancer	3.1e-06	2.73e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—MYC—kidney cancer	3.09e-06	2.72e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—POMC—kidney cancer	3.07e-06	2.71e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—MAPK1—kidney cancer	3.06e-06	2.7e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—MAPK1—kidney cancer	3.06e-06	2.7e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CDKN1B—kidney cancer	3.06e-06	2.7e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—MYC—kidney cancer	3.06e-06	2.7e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—PIK3CA—kidney cancer	3.06e-06	2.69e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PTGS2—kidney cancer	3.05e-06	2.69e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PTGS2—kidney cancer	3.05e-06	2.69e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—MAPK3—kidney cancer	3.04e-06	2.68e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—MAPK1—kidney cancer	3.02e-06	2.66e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	3.01e-06	2.65e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CDKN1B—kidney cancer	3.01e-06	2.65e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—TP53—kidney cancer	3e-06	2.65e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—POMC—kidney cancer	3e-06	2.64e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL2—kidney cancer	3e-06	2.64e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—MAPK1—kidney cancer	2.99e-06	2.64e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—KRAS—kidney cancer	2.99e-06	2.64e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—TP53—kidney cancer	2.96e-06	2.61e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	2.96e-06	2.6e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL2—kidney cancer	2.95e-06	2.6e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—MAPK3—kidney cancer	2.94e-06	2.59e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—MAPK3—kidney cancer	2.94e-06	2.59e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL2—kidney cancer	2.94e-06	2.59e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CCND1—kidney cancer	2.92e-06	2.57e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—JUN—kidney cancer	2.91e-06	2.57e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—VEGFA—kidney cancer	2.9e-06	2.55e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—MAPK1—kidney cancer	2.89e-06	2.55e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—KRAS—kidney cancer	2.89e-06	2.55e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—KRAS—kidney cancer	2.89e-06	2.55e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL2—kidney cancer	2.89e-06	2.55e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CTNNB1—kidney cancer	2.89e-06	2.55e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CCND1—kidney cancer	2.87e-06	2.53e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—JUN—kidney cancer	2.87e-06	2.53e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CCND1—kidney cancer	2.87e-06	2.53e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—JUN—kidney cancer	2.86e-06	2.52e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—KRAS—kidney cancer	2.86e-06	2.52e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	2.85e-06	2.51e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GSTP1—kidney cancer	2.85e-06	2.51e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CTNNB1—kidney cancer	2.84e-06	2.5e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—KRAS—kidney cancer	2.83e-06	2.49e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—POMC—kidney cancer	2.83e-06	2.49e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CCND1—kidney cancer	2.82e-06	2.48e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—PTEN—kidney cancer	2.82e-06	2.48e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—JUN—kidney cancer	2.82e-06	2.48e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—MAPK3—kidney cancer	2.81e-06	2.47e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—MAPK1—kidney cancer	2.8e-06	2.47e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—MAPK1—kidney cancer	2.8e-06	2.47e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	2.79e-06	2.46e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—PTEN—kidney cancer	2.77e-06	2.44e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PTEN—kidney cancer	2.77e-06	2.44e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—PTEN—kidney cancer	2.77e-06	2.44e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PTEN—kidney cancer	2.77e-06	2.44e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PTEN—kidney cancer	2.75e-06	2.42e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—PIK3CA—kidney cancer	2.75e-06	2.42e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MAPK3—kidney cancer	2.74e-06	2.42e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—KRAS—kidney cancer	2.73e-06	2.41e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—MYC—kidney cancer	2.73e-06	2.41e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—RAF1—kidney cancer	2.73e-06	2.4e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—PTEN—kidney cancer	2.72e-06	2.4e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MAPK3—kidney cancer	2.72e-06	2.39e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MAPK3—kidney cancer	2.72e-06	2.39e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—RELA—kidney cancer	2.72e-06	2.39e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—ERBB2—kidney cancer	2.7e-06	2.38e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—PIK3CA—kidney cancer	2.7e-06	2.38e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ABCB1—kidney cancer	2.69e-06	2.37e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—MAPK1—kidney cancer	2.67e-06	2.35e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MYC—kidney cancer	2.67e-06	2.35e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MTOR—kidney cancer	2.66e-06	2.35e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PTEN—kidney cancer	2.66e-06	2.35e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PTEN—kidney cancer	2.66e-06	2.35e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—PIK3CA—kidney cancer	2.66e-06	2.34e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—PIK3CA—kidney cancer	2.66e-06	2.34e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—KRAS—kidney cancer	2.64e-06	2.33e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—KRAS—kidney cancer	2.64e-06	2.33e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MYC—kidney cancer	2.64e-06	2.33e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MYC—kidney cancer	2.64e-06	2.33e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—RAF1—kidney cancer	2.64e-06	2.32e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—RAF1—kidney cancer	2.64e-06	2.32e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.64e-06	2.32e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—RELA—kidney cancer	2.63e-06	2.31e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—RELA—kidney cancer	2.63e-06	2.31e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—PIK3CA—kidney cancer	2.62e-06	2.31e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GSTM1—kidney cancer	2.61e-06	2.3e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—ERBB2—kidney cancer	2.61e-06	2.3e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—ERBB2—kidney cancer	2.61e-06	2.3e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MAPK1—kidney cancer	2.61e-06	2.3e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—PIK3CA—kidney cancer	2.6e-06	2.29e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MAPK1—kidney cancer	2.59e-06	2.28e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MAPK1—kidney cancer	2.59e-06	2.28e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MTOR—kidney cancer	2.58e-06	2.27e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MTOR—kidney cancer	2.58e-06	2.27e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—VEGFA—kidney cancer	2.55e-06	2.24e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TP53—kidney cancer	2.54e-06	2.24e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—KRAS—kidney cancer	2.52e-06	2.22e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TP53—kidney cancer	2.51e-06	2.21e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—PIK3CA—kidney cancer	2.51e-06	2.21e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—VEGFA—kidney cancer	2.5e-06	2.21e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CDKN1B—kidney cancer	2.5e-06	2.2e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—VEGFA—kidney cancer	2.5e-06	2.2e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.48e-06	2.18e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—KRAS—kidney cancer	2.46e-06	2.17e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—VEGFA—kidney cancer	2.46e-06	2.17e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTGS2—kidney cancer	2.45e-06	2.16e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL2—kidney cancer	2.45e-06	2.15e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—KRAS—kidney cancer	2.44e-06	2.15e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—KRAS—kidney cancer	2.44e-06	2.15e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—PIK3CA—kidney cancer	2.43e-06	2.14e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—PIK3CA—kidney cancer	2.43e-06	2.14e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CDKN1B—kidney cancer	2.42e-06	2.13e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CDKN1B—kidney cancer	2.42e-06	2.13e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MAPK3—kidney cancer	2.41e-06	2.12e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—POMC—kidney cancer	2.39e-06	2.11e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTGS2—kidney cancer	2.39e-06	2.11e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCND1—kidney cancer	2.39e-06	2.1e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—JUN—kidney cancer	2.38e-06	2.1e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MAPK3—kidney cancer	2.37e-06	2.09e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL2—kidney cancer	2.37e-06	2.08e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL2—kidney cancer	2.37e-06	2.08e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MAPK3—kidney cancer	2.36e-06	2.08e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CTNNB1—kidney cancer	2.36e-06	2.08e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MYC—kidney cancer	2.34e-06	2.06e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MAPK3—kidney cancer	2.33e-06	2.05e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—PIK3CA—kidney cancer	2.32e-06	2.04e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCND1—kidney cancer	2.31e-06	2.03e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCND1—kidney cancer	2.31e-06	2.03e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MYC—kidney cancer	2.3e-06	2.03e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—JUN—kidney cancer	2.3e-06	2.03e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—JUN—kidney cancer	2.3e-06	2.03e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PTEN—kidney cancer	2.3e-06	2.03e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MYC—kidney cancer	2.3e-06	2.03e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MAPK1—kidney cancer	2.29e-06	2.02e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CTNNB1—kidney cancer	2.28e-06	2.01e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CTNNB1—kidney cancer	2.28e-06	2.01e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	2.26e-06	1.99e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MYC—kidney cancer	2.26e-06	1.99e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MAPK1—kidney cancer	2.25e-06	1.99e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTGS2—kidney cancer	2.25e-06	1.99e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MAPK1—kidney cancer	2.25e-06	1.98e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—PIK3CA—kidney cancer	2.24e-06	1.98e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—PIK3CA—kidney cancer	2.24e-06	1.98e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PTEN—kidney cancer	2.23e-06	1.96e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PTEN—kidney cancer	2.23e-06	1.96e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MAPK1—kidney cancer	2.21e-06	1.95e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TP53—kidney cancer	2.19e-06	1.93e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—KRAS—kidney cancer	2.16e-06	1.91e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTEN—kidney cancer	2.14e-06	1.88e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—KRAS—kidney cancer	2.13e-06	1.88e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—KRAS—kidney cancer	2.12e-06	1.87e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—KRAS—kidney cancer	2.09e-06	1.84e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTEN—kidney cancer	2.09e-06	1.84e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—VEGFA—kidney cancer	2.08e-06	1.83e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—VEGFA—kidney cancer	2.01e-06	1.77e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—VEGFA—kidney cancer	2.01e-06	1.77e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—PIK3CA—kidney cancer	1.99e-06	1.75e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MAPK3—kidney cancer	1.97e-06	1.73e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTEN—kidney cancer	1.97e-06	1.73e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	1.96e-06	1.72e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PIK3CA—kidney cancer	1.95e-06	1.72e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—PIK3CA—kidney cancer	1.95e-06	1.72e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.95e-06	1.72e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PIK3CA—kidney cancer	1.94e-06	1.71e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TP53—kidney cancer	1.92e-06	1.69e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	1.92e-06	1.69e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MYC—kidney cancer	1.91e-06	1.68e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTGS2—kidney cancer	1.91e-06	1.68e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MAPK3—kidney cancer	1.9e-06	1.68e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MAPK3—kidney cancer	1.9e-06	1.68e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TP53—kidney cancer	1.89e-06	1.67e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TP53—kidney cancer	1.89e-06	1.66e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PIK3CA—kidney cancer	1.88e-06	1.65e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PIK3CA—kidney cancer	1.88e-06	1.65e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MAPK1—kidney cancer	1.87e-06	1.65e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TP53—kidney cancer	1.86e-06	1.64e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MYC—kidney cancer	1.85e-06	1.63e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MYC—kidney cancer	1.85e-06	1.63e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—POMC—kidney cancer	1.85e-06	1.63e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MAPK1—kidney cancer	1.81e-06	1.59e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MAPK1—kidney cancer	1.81e-06	1.59e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—KRAS—kidney cancer	1.77e-06	1.56e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—KRAS—kidney cancer	1.71e-06	1.51e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—KRAS—kidney cancer	1.71e-06	1.51e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTEN—kidney cancer	1.67e-06	1.47e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PIK3CA—kidney cancer	1.62e-06	1.43e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TP53—kidney cancer	1.57e-06	1.38e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3CA—kidney cancer	1.57e-06	1.38e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3CA—kidney cancer	1.57e-06	1.38e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TP53—kidney cancer	1.52e-06	1.34e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TP53—kidney cancer	1.52e-06	1.34e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.51e-06	1.33e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTGS2—kidney cancer	1.47e-06	1.3e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CA—kidney cancer	1.47e-06	1.3e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.39e-06	1.22e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTEN—kidney cancer	1.29e-06	1.13e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.18e-06	1.03e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CA—kidney cancer	9.07e-07	7.99e-06	CbGpPWpGaD
